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Abstract: Prior to 2011 legislation prohibiting children from using commercial sunbeds, the preva-
lence of sunbed use in 15- to 17-year-olds in some areas in England was as high as 50%. Despite
significant decreases since 2011, children today still practice indoor tanning. We estimated current
sunbed use in 11- to 17-year-olds in England, the number of available commercial sunbed units, and
the associated cost of a ‘buy-back’ scheme to remove commercial sunbeds under a potential future
policy to ban sunbeds. We undertook a calibration approach based on published prevalence rates
in English adults and other sources. Internet searches were undertaken to estimate the number of
sunbed providers in Greater Manchester, then we extrapolated this to England. Estimated mean
prevalence of sunbed use was 0.6% for 11- to 14-year-olds and 2.5% for 15- to 17-year-olds, equating
to 62,130 children using sunbeds in England. A predicted 2958 premises and 17,865 sunbeds exist
nationally and a ‘buy-back’ scheme would cost approximately GBP 21.7 million. Public health
concerns remain greatest for 11- to 17-year-olds who are particularly vulnerable to developing skin
cancers after high ultraviolet exposure.
Keywords: indoor tanning; sunbeds; children; prevalence
1. Introduction
Emitted ultraviolet radiation (UVR) from indoor tanning devices such as sunbeds or
tanning lamps can reach high to extreme levels [1]. To protect children from harmful expo-
sure to UVR and prevent keratinocyte skin cancers and melanomas, England prohibited
commercial sunbed use among under 18-year-olds in 2011. Commercial sunbeds relate to
stand-alone premises and those located within gymnasiums and leisure centres or health
clubs. Prior to 2011, the average prevalence of sunbed use across England was reported to
be 6% in 11- to 17-year-olds but as high as 50% in 15- to 17-year-old girls in some northern
cities [2]. Furthermore, over 50% of children using sunbeds reported they had suffered
burns and 25% reported unsupervised use [2].
Since the 2009 classification of indoor tanning devices as carcinogenic to humans by
the International Agency for Research on Cancer (IARC) [3], over 20 countries have now
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legislated against indoor tanning in persons aged under 18 years (or lower) [4]. Going
further, Australia, Brazil and Iran have outright bans on all commercial indoor tanning
services [5]. Other countries have introduced various restrictions such as preventing indoor
tanning by UV-sensitive people, banning unsupervised access, licensing indoor tanning
establishments, mandating operator training and taxing indoor tanning sessions.
The combined influence of the IARC statement [3], consumer educational campaigns
and warning notices [6] has led to sunbed use among children aged 11 to 17 years across
Europe to nearly halve from 12.5% [4]. Despite this favourable trend, prevalence at 6.7%
(95% Confidence Interval (CI): 4.4 to 9.6%) [4] remains concerning and banning use by
children may not go far enough in deterring sunbed use in those < 18 years. In the United
States, there are high levels of indoor tanning among 18-year-olds and college students
when indoor tanning becomes legal [7]. The current extent of sunbed use among children
in England is unknown but is likely to continue while the commercial provision of indoor
tanning remains available to adults. Adolescents will side-step legislation and use sunbeds
if regulatory enforcement of the law is lax [8], or when their parents allow them to use
privately-owned sunbeds in their homes [9]. In a school environment, older peers and
social media may also exert influence on their younger classmates [7], as well as the effects
of wider media and social media.
Over 15,000 people in the United Kingdom are currently diagnosed with melanoma
each year and there have been over 2000 deaths annually since 2007 [10]. On average, the
number of new cases of melanoma in the UK among young people aged up to 24 years is
170 and 161 for keratinocyte skin cancer, rising to 482 and 505, respectively, in those aged
up to 29 years [10]. The incidence of melanoma has increased 30% since 2007 [10] and calls
to ban all commercial tanning have reignited [7]. Such planned legislation would likely
meet with resistance from commercial operators and other interested parties who claim
consumer benefits of sunbed use, claims that have been dismissed by the World Health
Organization’s (WHO) report: Artificial tanning devices: public health interventions to
manage sunbeds [6].
Primary motivating factors as to why young people engage in tan-seeking behaviours
relate to aesthetics, the desire to look tanned and to feel better and more confident with
perceived attractiveness associated with tanned skin (Eden et al. forthcoming). Females
between the ages of 12 to 30 years are the key users of sunbeds [2,4] and commercial
tanning outlets offer cheap and easy access to tanning facilities. These perceptions, coupled
with an impetus for use ahead of milestone birthdays, end-of-school formal events or
getting together with friends while tanning [11], create a socially acceptable demand for
indoor tanning. Quantifying the current scale of sunbed provision identifies a baseline
against which to assess the impact of any future ban on sunbed providers and informs
the potential cost of a ‘buy-back’ scheme. A ‘buy-back’ approach has been successful in
Australia [12] in transitioning to a legislative ban, encouraging the removal of sunbeds
from the market and financially compensating sunbed providers for enforced changes to
their business. In light of this, the purpose of this study was to estimate: the prevalence of
sunbed use among children in England, the number of commercial tanning units and the
costs of a potential ‘buy-back’ scheme.
2. Materials and Methods
No ethical approval was required as this study did not involve data collection but
used existing published data.
Sunbed use prevalence: Gender-specific sunbed use prevalence at each age between 11
and 17 years was estimated based on numerous known and informed variables for England
in 2020 [2,13–15]. For the purposes of derivation: prevalence for an age x was defined as
the proportion of people having ever used a sunbed by their xth birthday; incidence for an
age x was defined as the proportion of people using sunbeds for the first time when they
are x years old. Sunbed use prevalence amongst 11–14-, 15–17- and 11–17-year-olds was
calculated based on mid-year estimates for the relevant years.
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Incidence was assumed to rise between the ages of 11 and 17 years. Following
precedents in the literature [14], each year’s incidence was modelled as a multiple of
the previous year’s. To ensure the 11- to 17-year-old model was consistent with sunbed
prevalence estimates for young adults [15], a surge in incidence was also modelled at the
18-year threshold when sunbeds become legal in England using a one-off multiplier and
the resulting young adult prevalence compared with published estimates. A published
ratio of female-to-male use was used to apportion overall use between adolescent women
and men [15].
Estimates of sunbed use prevalence reported from a recent meta-analysis (24) and from
a Europe-wide study [15] reveal a declining trend in use since IARC’s 2009 UVR-carcinogen
statement [3]. Comparing estimates from the two studies suggests European sunbed use
is falling by 14% every two years. Published point estimates for 15- to 19-year-old use in
England from before the 2010 ban on sunbeds for under 18-year-olds [2] were projected
to 2020 based on this two-yearly proportional decrease. Comparing the English projected
estimate with <20-year-old European prevalence for 2020, extrapolated using the same
trend from the 2012 and 2014 estimates, indicated that the ban further reduced sunbed use
in adolescents by 39 percentage points [14,16].
Estimates of sunbed use prevalence amongst 11–14, 15–17 and 11–17-year-olds from
2008 were projected to 2020 based on the downward European trend and effect of the
English ban [2]. The confidence intervals of the adjusted estimates were used as targets to
calibrate the parameters of a sunbed use prevalence curve for English adolescents. Sunbed
use was assumed to be at any indoor tanning location, either in a commercial facility or
at home. The following parameters and plausible sensitivity analysis values (in brackets)
were used to plot the final curve:
• 11-year-old prevalence of 0.1% (0.0, 0.2%) and incidence of 0.2% (0.1, 0.3%);
• Multiplicative year-on-year increase in incidence between ages 11–17 of 33.3% (23, 43%);
• Female:male ratio of 2.11:1, from a published Irish sample of both adults and adoles-
cents [15].
Estimated number of commercial sunbed units in England: We assessed two popula-
tions, Greater Manchester and the whole of England. Sunbed unit prevalence in Greater
Manchester was chosen as the locality to inform extrapolation to the whole of England.
Greater Manchester is a large metropolitan county, about one-third the population size of
Greater London, and comprising a mix of rural and urban residential areas. It contains
ten local authorities; two cities (Manchester and Salford) along with eight metropolitan
boroughs. Greater Manchester is socio-economically diverse with areas of both low and
high deprivation. Therefore, sensitivity analyses were undertaken for low and high values
for the estimated number of beds per provider.
Google and Google Maps searches for sunbed providers in each of the 10 local au-
thorities of Greater Manchester were undertaken in April 2020 [17,18]. Information from
one national chain of sunbed shops and two national health club chains was also used.
Commercial sunbed providers were classified as either small sunbed shop or large sunbed
shops. For each of these types of providers, an assumption was made about the typical
number of beds provided per commercial provider based on information from sunbed
users who were close contacts of the research team. To extrapolate a figure for England,
a per-person sunbed annual rate was subsequently calculated by dividing the estimated
number of sunbeds in Greater Manchester by the population of all people living in the area
in 2019 (n = 2,835,686) [19]. This annual rate was applied to the population of England in
2019 (n = 56,287,000) [19]. Sensitivity values for the number of sunbeds per different type
of premise were used to calculate a range of plausible estimates.
Cost of a ‘Buy-Back’ Scheme
In a potential ‘buy-back’ scheme, all current commercial providers of sunbeds would
be offered a per-sunbed amount of compensation ahead of the ban to have sunbeds removed
from their premises. Three per-sunbed unit costs were calculated based on the different
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amounts used in three existing Australian state-based buy-back schemes in 2014 (AUD
1000, 2000 or 5000 (C. Sinclair, personal communication)). These costs were inflated to 2020
prices [20] and translated into GBP using the https://www.xe.com/currency converter
(August 2020). The respective three exemplar per-unit buy-back costs were then: GBP 603,
GBP 1207 or GBP 3017.
3. Results
3.1. Sunbed Use Prevalence
The estimated mean prevalence of sunbed use overall was 1.5% for 11 to 17 years,
comprising 0.6% in 11- to 14-year-olds and 2.5% in 15- to 17-year-olds (Figure 1). Prevalence
of sunbed use for 11–14-year-old females was 0.9%, and 0.4% for males, compared with
15–17-year-old females at 3.4% and males at 1.6%. Applying this to the population of
children in England aged 11 to 17 years, by age and gender, equates to 62,130 children
estimated to be using sunbeds. Sensitivity analyses show that the overall prevalence may
vary between 0.8 to 2.1% (Table 1) and this is mostly driven by the change in incidence rate
per year of age.
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Figure 1. Percentage of 11- to 17-year-olds estimated to use sunbeds in England.
Table 1. One-way sensitivity analyses of prevalence of sunbed use in 11- to 17-year-olds.
Mean by Age Group Overall
11–14-Year-Olds 15–17-Year-Olds 11–17-Year-Olds
Base case 0.63% 2.53% 1.45%
11-year-old prevalence (base 0.10%)
0.00% 0.53% 2.43% 1.35%
.20 0.73% 2.63% 1. 5%
11-year-old incidence (base 0.2%)
0.10% 0.37% 1.31% 0.77%
0.30% 0.90% 3.74% 2.12%
Increase in incidence per year (base 33.3%)
23% 0.59% 2.00% 1.19%
43% 0.68% 3.16% 1.74%
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3.2. Estimated Number of Commercial Sunbed Units in England
The number of beds per provider were six beds for a small shop and eight for a
larger shop. In Greater Manchester, there were an estimated 900 commercial sunbeds in
current use (Table 2). Extrapolating from a per-capita Greater Manchester figure (1 sunbed
per 3152 residents), there are an estimated 17,865 commercial sunbed devices across Eng-
land. With an average of 6.04 sunbeds per commercial provider based on Greater Manch-
ester assumptions, we estimated that England has 2958 commercial sunbed providers
(17,865 sunbed units) in operation. Sensitivity analyses showed the number of providers
for England could vary between 1518 and 3917, translating to a total number of sunbed
devices between 9170 and 23,661.
Table 2. Estimated number of providers of commercial sunbeds and units in Greater Manchester.
Type of
Sunbed Provider Number of Providers







Small sunbed shops 146 6 (3, 8) 876 438,1168
Large sunbed shops 3 8 (7, 12) 24 21,36
Total Mean 6.04 (3.10, 6.12) 900 462,1192
1. Using data for April 2020. Source: small sunbed shops have six devices, larger sunbed shops are part of chains.
3.3. Cost of a ‘Buy-Back’ Scheme
Three estimated ‘buy-back’ scheme costs from both a regional and national perspective
are detailed in Table 3. For Greater Manchester, depending on unit costs used, a scheme
could cost between nearly GBP 550k up to almost GBP 2.8 million for the total sunbed units.
From a national perspective, it is predicted that a scheme would cost GBP 21.7 million, or
between ~GBP 11 million and ~GBP 55 million.
Table 3. Estimated cost of buy-back schemes.




















* Assumption based on local council charges for removing large appliances (https://www.salford.gov.uk).
4. Discussion
Our study showed that the current prevalence of sunbed use among children in
England may be around 1.5% (or over 62,000 individuals) and around 18,000 commercial
sunbed units are likely to be in operation, awaiting uptake of indoor tanning when these
children turn 18 years old. Girls are twice as likely to use sunbeds as boys, but for both
sexes, sunbed use substantially rises in the 15–17-year-old age groups. Since exposure
to UVR is the predominant cause of keratinocyte skin cancers and melanoma [3], these
cancers are largely preventable by reducing personal exposure to UV radiation through sun
protection [21] or avoiding indoor tanning [22]. Early onset melanoma in youth is serious
and the most frequently diagnosed cancer in young adults [23]. With rising melanoma
mortality rates every year in many countries, including England, more needs to be done to
prevent this disease. Public health concerns are greatest for youths who are particularly
vulnerable to skin cancers after high UV exposure [6]. The data presented here may be used
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in subsequent economic analyses of the impact of banning sunbeds and provide further
evidence for the case for a ban on commercial sunbed services in England.
For perceived aesthetic reasons, indoor tanning is likely to continue to be a popular
activity among youth in Europe, the Americas and Canada. While banning children’s
sunbed use is a positive step to reduce the burden of skin cancers, these gains may be
quickly reversed if parents are users of sunbeds and influence uptake in their teenage
children. Furthermore, using a sunbed may be seen as safe once children are older if there
is no legislation in place. In a large study in France, parents with a lower understanding
of sun safety measures and less stringent protection behaviours had children engaging in
fewer sun protection practices than children of parents who did practise sun protection [24].
Legislation banning commercial sunbeds sends a clear message from the government that
they are protecting citizens’ health, and moreover it is highly likely to be an investment
that will save healthcare costs in the longer-term [14,16].
A ‘buy-back’ scheme may cost the government upwards of GBP 55 million but notably,
is a one-off investment for a permanent solution to remove access to young people, the
primary users of sunbeds. It is feasible that resources are higher for auditing and enforce-
ment of an under 18s ban compared with a complete ban, due to their ongoing nature and
the substantial volume of sunbed businesses to manage. Compliance with age restriction
legislation prior to 2011 was poor in Chile, the US and Australia, with compliance at just
34% (mean) after in-person inquiries (range 20–62%) [8]. Even if compliance to the current
under 18s ban in England were 80%, and assuming our estimated 1.5% prevalence to be
home-use only, a total of 77,663 (62,130/0.80) 11- to 17-year-olds could be using sunbeds
across England. While non-compliance to a full ban is also possible, it was demonstrated to
be a minor and temporary problem in the state of Victoria, Australia [12]. A further benefit
of banning sunbeds is the avoidance of serious blistering and erythema, and potential
hospitalizations that occur for sunbed-induced burns [13,25], as well as avoidance of eye
damage [6].
Estimating the number of commercial sunbed units in Greater Manchester was chal-
lenging. A geographical gradient in England is evident in sunbed use with northern
England having higher sunbed use than southern areas [2]. The estimated number of
providers in Greater Manchester is likely to be a conservative estimate because not all
providers will have been identified using Google and Google Maps searches. Stark dis-
parities in the identified number of providers in the neighbouring (and similarly sized in
terms of population) local authorities provides an indication of the potential underesti-
mation. Whilst Greater Manchester is socioeconomically and geographically diverse, we
acknowledge that caution should be exercised in interpreting the extrapolated England-
wide estimate, given previously reported regional variation in sunbed use [2]. Further
research could be conducted within a sample of English local authorities to triangulate
these findings.
In calculating the ‘buy-back’ scheme cost estimates, several assumptions have necessar-
ily been made as mentioned above regarding the estimated numbers of sunbed providers.
The Sunbed Association’s website states the organization represents “a significant section
of the tanning facilities in the UK and Ireland” (https://www.sunbedassociation.org.uk/),
but membership of the Association is voluntary so does not provide a definitive list of all
UK sunbed providers. In a decade-old report, the South West Public Health Observatory’s
Cancer Intelligence Service estimated the number of facilities for sunbed use in the UK was
a total of 5350. Within that report, the Sunbed Association provided a personal communi-
cation with their estimation that approximately 8000 sunbed providers were in operation
during 2006. By attaching a plausible range of unit costs to the number of commercial
sunbeds, an early indicative overview of the potential impact of buy-back schemes in the
England context has been provided. In Australia, ‘buy-back’ schemes were undertaken to
remove commercial sunbeds from premises during the time that bans were enforced. For
example, in Victoria, Australia, ahead of the 2014 ban, operators were offered AUD 2000
(approximately GBP 1200 today) for each unit. Funded by the Australian government, it
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was estimated to cost between AUD 400,000 and AUD 750,000 (GBP 250 k to GBP 457 k) for
the scheme in the state of Victoria alone [26]. However, these upfront costs are equivalent in
value to the avoided incidence of only five or six patients with advanced stage melanoma
and the attendant very high costs of immunotherapy treatments.
Factors other than geographic location, gender and legislation influence sunbed
use among teenagers and they need to be further explored by future studies. Low self-
confidence, high social pressure and cultural beauty standards prompt individuals to use
a sunbed for the first time [27]. The identification of the most susceptible subgroups to
indoor tanning among the general population is key to ensure successful outcomes from
campaigns targeting sunbed use. Other successful contributors to introducing sunbed
legislation include measures to counteract the strong marketing strategies from the tanning
bed industry and anti-‘nanny state’ attitudes, while enhancing the need for strong advocacy
and key influencers (e.g., dermatologists in favour of banning sunbeds) and addressing
other methods of increasing confidence among children.
5. Conclusions
Sunbed use among children aged 11- to 14-years-old in England is estimated to be
0.6% per year, rising to 2.5% among 15- to 17-year-olds. This translates to potentially
62,000 children across England engaging in indoor tanning, known to be harmful and
cause skin cancers in users. The estimated number of commercial sunbed devices is
approximately 18,000 in England. These findings provide the basis for subsequent economic
analyses of the impact of banning commercial sunbeds in England.
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